Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis

Shiue Luen Chen, Chong You Chen, Jason Chia Hsun Hsieh, Zih Yu Yu, Sheng Jen Cheng, Kuan Yu Hsieh, Jia Wei Yang, Priyank V. Kumar, Shien Fong Lin, Guan Yu Chen

Research output: Contribution to journalReview article

Abstract

Liquid biopsies use blood or urine as test samples, which are able to be continuously collected in a non-invasive manner. The analysis of cancer-related biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA, and exosomes provides important information in early cancer diagnosis, tumor metastasis detection, and postoperative recurrence monitoring assist with clinical diagnosis. However, low concentrations of some tumor markers, such as CTCs, ctDNA, and microRNA, in the blood limit its applications in clinical detection and analysis. Nanomaterials based on graphene oxide have good physicochemical properties and are now widely used in biomedical detection technologies. These materials have properties including good hydrophilicity, mechanical flexibility, electrical conductivity, biocompatibility, and optical performance. Moreover, utilizing graphene oxide as a biosensor interface has effectively improved the sensitivity and specificity of biosensors for cancer detection. In this review, we discuss various cancer detection technologies regarding graphene oxide and discuss the prospects and challenges of this technology.

Original languageEnglish (US)
Article number1725
JournalNanomaterials
Volume9
Issue number12
DOIs
StatePublished - Dec 2019
Externally publishedYes

Fingerprint

Graphite
Biopsy
Biosensors
Oxides
Graphene
Tumors
Liquids
MicroRNAs
DNA
Blood
Hydrophilicity
Biomarkers
Tumor Biomarkers
Biocompatibility
Nanostructured materials
Materials properties
Cells
Monitoring

Keywords

  • Circulating tumor cells
  • Circulating tumor DNA
  • Exosome
  • Graphene oxide
  • Liquid biopsy

ASJC Scopus subject areas

  • Chemical Engineering(all)
  • Materials Science(all)

Cite this

Chen, S. L., Chen, C. Y., Hsieh, J. C. H., Yu, Z. Y., Cheng, S. J., Hsieh, K. Y., ... Chen, G. Y. (2019). Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis. Nanomaterials, 9(12), [1725]. https://doi.org/10.3390/nano9121725

Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis. / Chen, Shiue Luen; Chen, Chong You; Hsieh, Jason Chia Hsun; Yu, Zih Yu; Cheng, Sheng Jen; Hsieh, Kuan Yu; Yang, Jia Wei; Kumar, Priyank V.; Lin, Shien Fong; Chen, Guan Yu.

In: Nanomaterials, Vol. 9, No. 12, 1725, 12.2019.

Research output: Contribution to journalReview article

Chen, SL, Chen, CY, Hsieh, JCH, Yu, ZY, Cheng, SJ, Hsieh, KY, Yang, JW, Kumar, PV, Lin, SF & Chen, GY 2019, 'Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis', Nanomaterials, vol. 9, no. 12, 1725. https://doi.org/10.3390/nano9121725
Chen SL, Chen CY, Hsieh JCH, Yu ZY, Cheng SJ, Hsieh KY et al. Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis. Nanomaterials. 2019 Dec;9(12). 1725. https://doi.org/10.3390/nano9121725
Chen, Shiue Luen ; Chen, Chong You ; Hsieh, Jason Chia Hsun ; Yu, Zih Yu ; Cheng, Sheng Jen ; Hsieh, Kuan Yu ; Yang, Jia Wei ; Kumar, Priyank V. ; Lin, Shien Fong ; Chen, Guan Yu. / Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis. In: Nanomaterials. 2019 ; Vol. 9, No. 12.
@article{c5f2be1d3f344a4a9b557c2ee6cca3e0,
title = "Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis",
abstract = "Liquid biopsies use blood or urine as test samples, which are able to be continuously collected in a non-invasive manner. The analysis of cancer-related biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA, and exosomes provides important information in early cancer diagnosis, tumor metastasis detection, and postoperative recurrence monitoring assist with clinical diagnosis. However, low concentrations of some tumor markers, such as CTCs, ctDNA, and microRNA, in the blood limit its applications in clinical detection and analysis. Nanomaterials based on graphene oxide have good physicochemical properties and are now widely used in biomedical detection technologies. These materials have properties including good hydrophilicity, mechanical flexibility, electrical conductivity, biocompatibility, and optical performance. Moreover, utilizing graphene oxide as a biosensor interface has effectively improved the sensitivity and specificity of biosensors for cancer detection. In this review, we discuss various cancer detection technologies regarding graphene oxide and discuss the prospects and challenges of this technology.",
keywords = "Circulating tumor cells, Circulating tumor DNA, Exosome, Graphene oxide, Liquid biopsy",
author = "Chen, {Shiue Luen} and Chen, {Chong You} and Hsieh, {Jason Chia Hsun} and Yu, {Zih Yu} and Cheng, {Sheng Jen} and Hsieh, {Kuan Yu} and Yang, {Jia Wei} and Kumar, {Priyank V.} and Lin, {Shien Fong} and Chen, {Guan Yu}",
year = "2019",
month = "12",
doi = "10.3390/nano9121725",
language = "English (US)",
volume = "9",
journal = "Nanomaterials",
issn = "2079-4991",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Graphene oxide-based biosensors for liquid biopsies in cancer diagnosis

AU - Chen, Shiue Luen

AU - Chen, Chong You

AU - Hsieh, Jason Chia Hsun

AU - Yu, Zih Yu

AU - Cheng, Sheng Jen

AU - Hsieh, Kuan Yu

AU - Yang, Jia Wei

AU - Kumar, Priyank V.

AU - Lin, Shien Fong

AU - Chen, Guan Yu

PY - 2019/12

Y1 - 2019/12

N2 - Liquid biopsies use blood or urine as test samples, which are able to be continuously collected in a non-invasive manner. The analysis of cancer-related biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA, and exosomes provides important information in early cancer diagnosis, tumor metastasis detection, and postoperative recurrence monitoring assist with clinical diagnosis. However, low concentrations of some tumor markers, such as CTCs, ctDNA, and microRNA, in the blood limit its applications in clinical detection and analysis. Nanomaterials based on graphene oxide have good physicochemical properties and are now widely used in biomedical detection technologies. These materials have properties including good hydrophilicity, mechanical flexibility, electrical conductivity, biocompatibility, and optical performance. Moreover, utilizing graphene oxide as a biosensor interface has effectively improved the sensitivity and specificity of biosensors for cancer detection. In this review, we discuss various cancer detection technologies regarding graphene oxide and discuss the prospects and challenges of this technology.

AB - Liquid biopsies use blood or urine as test samples, which are able to be continuously collected in a non-invasive manner. The analysis of cancer-related biomarkers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), microRNA, and exosomes provides important information in early cancer diagnosis, tumor metastasis detection, and postoperative recurrence monitoring assist with clinical diagnosis. However, low concentrations of some tumor markers, such as CTCs, ctDNA, and microRNA, in the blood limit its applications in clinical detection and analysis. Nanomaterials based on graphene oxide have good physicochemical properties and are now widely used in biomedical detection technologies. These materials have properties including good hydrophilicity, mechanical flexibility, electrical conductivity, biocompatibility, and optical performance. Moreover, utilizing graphene oxide as a biosensor interface has effectively improved the sensitivity and specificity of biosensors for cancer detection. In this review, we discuss various cancer detection technologies regarding graphene oxide and discuss the prospects and challenges of this technology.

KW - Circulating tumor cells

KW - Circulating tumor DNA

KW - Exosome

KW - Graphene oxide

KW - Liquid biopsy

UR - http://www.scopus.com/inward/record.url?scp=85076603837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076603837&partnerID=8YFLogxK

U2 - 10.3390/nano9121725

DO - 10.3390/nano9121725

M3 - Review article

AN - SCOPUS:85076603837

VL - 9

JO - Nanomaterials

JF - Nanomaterials

SN - 2079-4991

IS - 12

M1 - 1725

ER -